{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:38:28Z","timestamp":1786451908584,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100023448","name":"Robert Koch-Institut","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023448","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In Germany, little is known about hepatitis B (HepB) prevalence and vaccination coverage among transgender and non-binary people (TNBP), a WHO-defined viral hepatitis key population. Our study aimed to assess self-reported HepB diagnoses, self-reported positive vaccination history, and potential predictors for a positive vaccination history in a subset of participants for whom the German standing committee on vaccination recommend HepB vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed data from a 2022 cross-sectional online survey of TNBP in Germany. We calculated percentages and prevalence ratios (PR) with 95% confidence intervals (CI). Predictors of a positive vaccination history among participants potentially recommended for HepB vaccination (e.g.\u2009&gt;\u20091 sexual partner in the last 12\u00a0months, people who inject drugs) were identified using a bootstrapped stepwise selection procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We analysed the answers from 2,358 participants. Of these, 0.6% (13\/2,358) reported previous HepB diagnosis and the proportion of self-reported positive vaccination history was 56.3% (1,225\/2,175). Positive vaccination history varied across subgroups, with higher proportions among participants identifying on the male spectrum than on the female (PR: 1.29; 95% CI: 1.14, 1.47) or non-binary spectrum (PR: 1.27; 95% CI: 1.13, 1.44), participants with higher education levels compared to lower (PR: 1.44, 95% CI: 1.26, 1.68), and in big cities compared to rural areas (PR: 1.22, 95% CI: 1.07, 1.41). Overall, 550 (21.7%) participants were identified as potentially being recommended for HepB vaccination, with a total of 213 participants reporting a negative HepB vaccination history. 65% of these 213 participants were younger than 30\u00a0years and should have received the recommended childhood HepB vaccination. The proportion of positive vaccination history increased with the number of hepatitis facts known. The bootstrapped stepwise selection procedure identified knowledge of hepatitis facts as potential predictor for a positive vaccination history (relative selection frequency: 100%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Self-reported HepB diagnoses were rare among participants and comparable to prevalence estimates in the general population in Germany. To reduce the number of TNBP with unmet vaccination needs and to improve vaccine uptake in this population, gaps in knowledge and lived experiences of TNBP need to be considered in the planning and implementation of targeted interventions. The collection of reliable data is essential on the road to achieve elimination by 2030.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-026-28677-3","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:59:08Z","timestamp":1786402748000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Self-reported hepatitis B diagnoses and vaccination history in trans and non-binary communities in Germany, the TASG-study* 2022"],"prefix":"10.1186","volume":"26","author":[{"given":"Renke","family":"Biallas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Burdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas A.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Spurgat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"P\u00f6ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Dudareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Koppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the TASG-study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00e9","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Ricardo","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hahne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Saalfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"28677_CR1","unstructured":"World Health Organization. Hepatitis B: key facts [ https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b]"},{"key":"28677_CR2","first-page":"2024","volume-title":"action for access in low- and middle-income countries","author":"Global hepatitis report","year":"2024","unstructured":"Global hepatitis report. action for access in low- and middle-income countries. In. Geneva: World Health Organization; 2024. p. 2024."},{"issue":"1","key":"28677_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40001-022-00677-0","volume":"27","author":"G Moradi","year":"2022","unstructured":"Moradi G, Soheili M, Rashti R, Dehghanbanadaki H, Nouri E, Zakaryaei F, et al. The prevalence of hepatitis C and hepatitis B in lesbian, gay, bisexual and transgender populations: a systematic review and meta-analysis. Eur J Med Res. 2022;27(1):47.","journal-title":"Eur J Med Res"},{"issue":"2","key":"28677_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00103-021-03478-8","volume":"65","author":"S Dudareva","year":"2022","unstructured":"Dudareva S, Faber M, Zimmermann R, Bock CT, Offergeld R, Steffen G, et al. Epidemiology of viral hepatitis A to E in Germany. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2022;65(2):149\u201358.","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"issue":"5\u20136","key":"28677_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00103-013-1673-x","volume":"56","author":"C Poethko-M\u00fcller","year":"2013","unstructured":"Poethko-M\u00fcller C, Zimmermann R, Hamouda O, Faber M, Stark K, Ross RS, et al. Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2013;56(5\u20136):707\u201315.","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"28677_CR6","doi-asserted-by":"crossref","unstructured":"Sperle I, Steffen G, Leendertz SA, Sarma N, Beermann S, Thamm R, Simeonova Y, Cornberg M, Wedemeyer H, Bremer V et al: Prevalence of Hepatitis B, C, and D in Germany: results from a scoping review. Front Public Health 2020;8.","DOI":"10.3389\/fpubh.2020.00424"},{"key":"28677_CR7","first-page":"3","volume-title":"Epid bull","author":"St\u00e4ndige Impfkommission","year":"2023","unstructured":"St\u00e4ndige Impfkommission. Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) beim Robert Koch-Institut 2023. In: Epid bull, vol. vol. 4. Epid Bull: Robert Koch-Institut; 2023. p. 3\u201368."},{"key":"28677_CR8","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1017\/S0950268820000163","volume":"148","author":"M Brandl","year":"2020","unstructured":"Brandl M, Schmidt AJ, Marcus U, An der Heiden M, Dudareva S. Are men who have sex with men in Europe protected from hepatitis B? Epidemiol Infect. 2020;148:e27.","journal-title":"Epidemiol Infect"},{"key":"28677_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06400-4","volume":"21","author":"G Steffen","year":"2021","unstructured":"Steffen G, Sperle I, Harder T, Sarma N, Beermann S, Thamm R, et al. Hepatitis B vaccination coverage in Germany: systematic review. BMC Infect Dis. 2021;21:1\u201317.","journal-title":"BMC Infect Dis"},{"key":"28677_CR10","first-page":"3","volume":"48","author":"T Rieck","year":"2022","unstructured":"Rieck T, Feig M, Siedler A. Impfquoten von Kinderschutzimpfungen in Deutschland \u2013 aktuelle Ergebnisse aus der RKI-Impfsurveillance. Epidemiol Bull. 2022;48:3\u201325.","journal-title":"Epidemiol Bull"},{"key":"28677_CR11","doi-asserted-by":"publisher","unstructured":"Brandl M, Schmidt AJ, Marcus U, Duffell E, Severi E, Mozalevskis A, Kivite-Urtane A, an der Heiden M, Dudareva S: Self-reported hepatitis A and B vaccination coverage among men who have sex with men (MSM), associated factors, and vaccination recommendations in 43 countries of the WHO European Region: results from the European MSM Internet Survey, EMIS-2017. Euro Surveill. 2024;29(45):2400100. https:\/\/doi.org\/10.2807\/1560-7917.","DOI":"10.2807\/1560-7917"},{"key":"28677_CR12","volume-title":"The report of the 2015 U.S. transgender survey","author":"SE James","year":"2016","unstructured":"James SE, Herman JL, Rankin S, Keisling M, Mottet L, Anafi M. The report of the 2015 U.S. transgender survey. Washington DC: National Center for Transgender Equality; 2016."},{"issue":"7","key":"28677_CR13","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.3390\/ijerph18073403","volume":"18","author":"E McCann","year":"2021","unstructured":"McCann E, Donohue G, Brown M. Experiences and perceptions of trans and gender non-binary people regarding their psychosocial support needs: a systematic review of the qualitative research evidence. Int J Environ Res Public Health. 2021;18(7):3403.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"28677_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12939-023-02023-0","volume":"22","author":"T Skuban-Eiseler","year":"2023","unstructured":"Skuban-Eiseler T, Orzechowski M, Steger F. Why do transgender individuals experience discrimination in healthcare and thereby limited access to healthcare? An interview study exploring the perspective of German transgender individuals. Int J Equity Health. 2023;22(1):211.","journal-title":"Int J Equity Health"},{"issue":"11","key":"28677_CR15","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1007\/s11606-021-07001-2","volume":"36","author":"DM Warner","year":"2021","unstructured":"Warner DM, Mehta AH. Identifying and addressing barriers to transgender healthcare: where we are and what we need to do about it. J Gen Intern Med. 2021;36(11):3559\u201361.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"28677_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/19317611.2021.1989535","volume":"34","author":"Z Hao","year":"2022","unstructured":"Hao Z, Guo Y, Bowling J, Ledenyi M. Facilitators and barriers of HPV vaccine acceptance, initiation, and completion among LGBTQ community in the U.S.: a systematic review. Int J Sex Health. 2022;34(2):291\u2013307.","journal-title":"Int J Sex Health"},{"issue":"3","key":"28677_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2105\/AJPH.2021.306599","volume":"112","author":"D Azucar","year":"2022","unstructured":"Azucar D, Slay L, Valerio DG, Kipke MD. Barriers to COVID-19 vaccine uptake in the LGBTQIA community. Am J Public Health. 2022;112(3):405\u20137.","journal-title":"Am J Public Health"},{"issue":"2","key":"28677_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/healthcare11020245","volume":"11","author":"JN Balaji","year":"2023","unstructured":"Balaji JN, Prakash S, Joshi A, Surapaneni KM. A scoping review on COVID-19 vaccine hesitancy among the lesbian, gay, bisexual, transgender, queer, intersex and asexual (LGBTQIA+) community and factors fostering its refusal. Healthcare (Basel). 2023;11(2):245.","journal-title":"Healthcare (Basel)"},{"key":"28677_CR19","unstructured":"P\u00f6ge K, Spurgat C, Hamm J, Koppe U: Forschungsbericht zum Projekt \u201cSexuelle Gesundheit und HIV\/STI in trans und nicht-bin\u00e4ren Communitys\u201d. 2023. [last accessed: 27.07.2026]https:\/\/www.rki.de\/DE\/Themen\/Infektionskrankheiten\/Infektionskrankheiten-A-Z\/H\/HIV-AIDS\/Studien\/TASG-Ergebnisse.html?nn=16911154"},{"issue":"4","key":"28677_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1026\/0012-1924.50.4.171","volume":"50","author":"K Gr\u00e4fe","year":"2004","unstructured":"Gr\u00e4fe K, Zipfel S, Herzog W, L\u00f6we B. Screening psychischer St\u00f6rungen mit dem \u201cGesundheitsfragebogen f\u00fcr Patienten (PHQ-D)\u201c. Diagnostica (Bologna). 2004;50(4):171\u201381.","journal-title":"Diagnostica (Bologna)"},{"issue":"9","key":"28677_CR21","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"key":"28677_CR22","doi-asserted-by":"publisher","unstructured":"L\u00f6we B, Decker O, M\u00fcller S et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical care. 2008;46:266\u2013274. https:\/\/doi.org\/10.1097\/MLR.0b013e318160d093.","DOI":"10.1097\/MLR.0b013e318160d093"},{"key":"28677_CR23","unstructured":"Log-binomial regression to estimate a risk ratio or prevalence ratio [https:\/\/www.bookdown.org\/rwnahhas\/RMPH\/]"},{"issue":"16","key":"28677_CR24","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1002\/sim.4780111607","volume":"11","author":"W Sauerbrei","year":"1992","unstructured":"Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the cox regression model. Stat Med. 1992;11(16):2093\u2013109.","journal-title":"Stat Med"},{"issue":"2","key":"28677_CR25","doi-asserted-by":"publisher","first-page":"2238576","DOI":"10.1080\/21645515.2023.2238576","volume":"19","author":"AL Esber","year":"2023","unstructured":"Esber AL, Streeck H, Jansen K, Dorsey-Spitz J, Robb ML, Crowell TA. High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in Germany. Hum Vaccin Immunother. 2023;19(2):2238576.","journal-title":"Hum Vaccin Immunother"},{"key":"28677_CR26","unstructured":"Gesundheitsberichterstattung des Bundes [] ; last accessed: 23.07.2026 https:\/\/www.gbe-bund.de"},{"key":"28677_CR27","doi-asserted-by":"publisher","first-page":"100608","DOI":"10.1016\/j.ssmph.2020.100608","volume":"11","author":"L Kcomt","year":"2020","unstructured":"Kcomt L, Gorey KM, Barrett BJ, McCabe SE. Healthcare avoidance due to anticipated discrimination among transgender people: a call to create trans-affirmative environments. SSM Popul Health. 2020;11:100608.","journal-title":"SSM Popul Health"},{"key":"28677_CR28","doi-asserted-by":"publisher","first-page":"100159","DOI":"10.1016\/j.dialog.2023.100159","volume":"3","author":"SD Thomas","year":"2023","unstructured":"Thomas SD, King R, Murphy M, Dempsey M. Demographic factors associated with healthcare avoidance and delay in the transgender population: findings from a systematic review. Dialogues Health. 2023;3:100159.","journal-title":"Dialogues Health"},{"issue":"3","key":"28677_CR29","doi-asserted-by":"publisher","first-page":"e0172310","DOI":"10.1371\/journal.pone.0172310","volume":"12","author":"M Marti","year":"2014","unstructured":"Marti M, de Cola M, MacDonald NE, Dumolard L, Duclos P. Assessments of global drivers of vaccine hesitancy in 2014\u2014looking beyond safety concerns. PLoS ONE. 2014;12(3):e0172310.","journal-title":"PLoS ONE"},{"issue":"1","key":"28677_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00103-019-03063-0","volume":"63","author":"KB Habersaat","year":"2020","unstructured":"Habersaat KB, Jackson C. Understanding vaccine acceptance and demand\u2014and ways to increase them. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2020;63(1):32\u20139.","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"issue":"5","key":"28677_CR31","doi-asserted-by":"publisher","first-page":"e243","DOI":"10.1097\/INF.0000000000003499","volume":"41","author":"J Tuckerman","year":"2022","unstructured":"Tuckerman J, Kaufman J, Danchin M. Effective approaches to combat vaccine hesitancy. Pediatr Infect Dis J. 2022;41(5):e243\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"21","key":"28677_CR32","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1016\/j.vaccine.2021.04.008","volume":"39","author":"M Xiridou","year":"2021","unstructured":"Xiridou M, Visser M, Urbanus A, Matser A, van Benthem B, Veldhuijzen I. Ending risk-group HBV vaccination for MSM after the introduction of universal infant HBV vaccination: a mathematical modelling study. Vaccine. 2021;39(21):2867\u201375.","journal-title":"Vaccine"},{"key":"28677_CR33","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2020.20392","volume":"150","author":"AJ Schmidt","year":"2020","unstructured":"Schmidt AJ, Rasi M, Esson C, Christinet V, Ritzler M, Lung T, et al. The Swiss STAR trial - an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men. Swiss Med Wkly. 2020;150:w20392.","journal-title":"Swiss Med Wkly"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-026-28677-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28677-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-026-28677-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:04:59Z","timestamp":1786449899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-026-28677-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["28677"],"URL":"https:\/\/doi.org\/10.1186\/s12889-026-28677-3","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was provided by the chamber of physicians in Berlin, Germany (reference: Eth-71\/21). The study was conducted in accordance with the principles of the Declaration of Helsinki.Participants had to consent to the study before being able to start the anonymous online survey.","order":1,"name":"Ethics","label":"Ethics approval and consent statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"UK owns \u2018Exchange-traded fund\u2019 (ETF) shares, which may include stocks of companies involved in healthcare. The authors report no conflicts of interest. This study was supported through funds of the German ministry of health due to a resolution of the German parliament. The other authors report no conflicts of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"2321"}}